/ BIOPHARMA COMPANY / ACQUIRED BY SHIRE IN 2014, SOLD TO MIRUM IN 2019
RiverVest co-founded and seed funded Lumena and built a clinical strategy to fast-track its lead drug compound through clinical trials.
Drawing on deep scientific expertise and relationships, the Lumena team tackled a significant unmet need and paved the way for safe, effective oral treatments for life-threatening liver diseases. Lumena was acquired by Shire less than 3 years after formation, delivering ~$400 million to investors. The story continues with Mirum.